Investment Case

  • Business Model

    Drug discovery and diagnostic product development typically follows established and well-defined processes. This involves sequential steps requiring a specific set of tools and technologies. This is often described as a…

    View
  • Company Overview

    This section is being edited. Please go back in a few days.

    View
  • Growth Markets

    Our mission is to provide researchers around the world with products and services to enhance and streamline their R&D effort thereby enabling scientific advancement and facilitating entry of newly developed…

    View
  • History

    4basebio AG, formally SYGNIS AG, is a stock-listed company based in Heidelberg, Germany.  Following strong support from investors, in July 2018, the company changed its company name from SYGNIS AG…

    View
  • Key Technologies

    Driving innovation through product development Innovation is what drives product development at 4basebio. Our objective is to move boundaries and develop products which will assist with the advancement of life sciences and…

    View
  • Strategy

    Our mission Our mission is to act as enablers and innovators for the markets we serve and strengthen our role as a strategic partner to our customers.  By doing so,…

    View